Osteoarthropathien und Periarthropathien bei Diabetes mellitus

Zusammenfassung

Eine steigende Lebenserwartung und Veränderungen im Lebensstil, die durch geringere körperliche Aktivität und eine höhere Aufnahme hochkalorischer Nahrungsmittel geprägt sind, tragen zu der weltweit steigenden Inzidenz von Diabetes mellitus bei. Neben den mikro- und makrovaskulären Komplikationen der Erkrankung haben Veränderungen am Skelettsystem einen beträchtlichen Anteil an der Komorbidität der Patienten. Von besonderer klinischer Bedeutung sind Arthropathien und Periarthropathien an den Händen, Schultern und Füßen. Obwohl diese Veränderungen mit der Dauer des Diabetes mellitus und mit dem Alter der Patienten zunehmen, konnte eine direkte Assoziation zur Stoffwechseleinstellung bisher nicht beschrieben werden. Die meisten skelettalen Komplikationen lassen sich anhand des klinischen Bildes diagnostizieren. Radiologische Befunde können ergänzend zur Differenzialdiagnose notwendig sein. Die Therapie der einzelnen Krankheitsbilder unterscheidet sich nicht von der Behandlung bei stoffwechselgesunden Patienten.

Abstract

Increasing life expectancy and changes in life style characterised by low physical activity and increased consumption of high-calorie foods contribute to the world-wide increasing incidence of diabetes mellitus. Besides the micro- and macrovascular complications of the disease, changes in the skeletal system contribute to a considerable extent to the patients’ comorbidity. Of particular clinical importance are arthropathies and periarthropathies of the hands, shoulders and feet. Although these changes increase with increasing duration of the disease and patient age, a direct association with the metabolic situation has not yet been established. Most of the skeletal complications can be diagnosed on the basis of their clinical features. Radiological findings may be necessary supplements for the differential diagnosis. Therapy for the individual clinical entities does not differ from that for metabolically healthy patients

Diabetes mellitus - Osteoporose - Karpaltunnelsyndrom - diabetisch-neuropathische Arthropathie - diffuse idiopathische skelettale Hyperostose

diabetes mellitus - osteoporosis - diabetic neuropathic osteoarthropathy - carpal tunnel syndrome - diffuse idiopathic skeletal hyperostosis

Literatur

• 1 Alberti K G, Zimmet P Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.  Diabet Med. 1998;  15 539-553
• 2 Genuth S, Alberti K G, Bennett P. et al . Follow-up report on the diagnosis of diabetes mellitus.  Diabetes care. 2003;  26 3160-3167
• 3 Cohen N D, Shaw J E. Diabetes: advances in treatment.  Intern Med J. 2007;  37 383-388
• 4 Johnell O, Kanis J A, Odén A. et al . Mortality after osteoporotic fractures.  Osteoporos Int. 2004;  15 38-42
• 5 Nicodemus K K, Folsom A R. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women.  Diabetes care. 2001;  24 1192-1197
• 6 Munoz-Torres M, Jodar E, Escobar-Jimenez F. et al . Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus.  Calcif Tissue Int. 1996;  58 316-319
• 7 Strotmeyer E S, Cauley J A, Orchard T J. et al . Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women.  Diabetes care. 2006;  29 306-311
• 8 Strotmeyer E S, Cauley J A, Schwartz A V. et al . Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study.  J Bone Miner Res. 2004;  19 1084-1091
• 9 Thrailkill K M, Lumpkin C K, Bunn R C. et al . Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.  Am J Physiol Endocrinol Metab. 2005;  289 E735-E745
• 10 Vashishth Jr D, Gibson G J, Khoury J I. et al . Influence of nonenzymatic glycation on biomechanical properties of cortical bone.  Bone. 2001;  28 195-201
• 11 Takeda S, Elefteriou F, Levasseur R. et al . Leptin regulates bone formation via the sympathetic nervous system.  Cell. 2002;  111 305-317
• 12 Kannus P, Sievänen H, Palvanen M. et al . Prevention of falls and consequent injuries in elderly people.  Lancet. 2005;  366 1885-1893
• 13 Bischoff H A, Stähelin H B, Dick W. et al . Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial.  J Bone Miner Res. 2003;  18 343-351
• 14 Balci N, Balci M K, Tüzüner S. Shoulder adhesive capsulitis and shoulder range of motion in type II diabetes mellitus: association with diabetic complications.  J Diabetes Complications. 1999;  13 135-140
• 15 Cagliero E, Apruzzese W, Perlmutter G S. et al . Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus.  Am J Med. 2002;  112 487-490
• 16 Thomas S J, McDougall C, Brown I D. et al . Prevalence of symptoms and signs of shoulder problems in people with diabetes mellitus.  J Shoulder Elbow Surg. 2007;  16 748-751
• 17 Lundbaek K. Stiff hands in long-term diabetes.  Acta Med Scand. 1957;  158 447-451
• 18 Kapoor A, Sibbitt W L. Contractures in diabetes mellitus: the syndrome of limited joint mobility.  Semin Arthritis Rheum. 1989;  18 168-180
• 19 Lu Y C, Wang P W, Liu R T. et al . Limited joint mobility of the hand: prevalence and relation to chronic complications in non-insulin-dependent diabetes mellitus patients.  J Formos Med Assoc. 1993;  92 139-143
• 20 Traisman H S, Traisman E S, Marr T J. et al . Joint contractures in patients with juvenile diabetes and their siblings.  Diabetes care. 1978;  1 360-361
• 21 Arkkila P E, Kantola I M, Viikari J S. Limited joint mobility in type 1 diabetic patients: correlation to other diabetic complications.  J Intern Med. 1994;  236 215-223
• 22 Sukenik Jr S, Weitzman S, Buskila D. et al . Limited joint mobility and other rheumatological manifestations in diabetic patients.  Diabete Metab. 1987;  13 187-192
• 23 Jennings A M, Milner P C, Ward J D. Hand abnormalities are associated with the complications of diabetes in type 2 diabetes.  Diabet Med. 1989;  6 43-47
• 24 Infante J R, Rosenbloom A L, Silverstein J H. et al . Changes in frequency and severity of limited joint mobility in children with type 1 diabetes mellitus between 1976 – 78 and 1998.  J Pediatr. 2001;  138 33-37
• 25 Salmela P I, Oikarinen A, Pirttiaho H. et al . Increased non-enzymatic glycosylation and reduced solubility of skin collagen in insulin-dependent diabetic patients.  Diabetes Res. 1989;  11 115-120
• 26 Chang K, Uitto J, Rowold E A. et al . Increased collagen cross-linkages in experimental diabetes: reversal by beta-aminopropionitrile and D-penicillamine.  Diabetes. 1980;  29 778-781
• 27 Kennedy L, Lyons T J. Non-enzymatic glycosylation.  Br Med Bull. 1989;  45 174-190
• 28 Yosipovitch G, Yosipovitch Z, Karp M. et al . Trigger finger in young patients with insulin dependent diabetes.  J Rheumatol. 1990;  17 951-952
• 29 Chammas M, Bousquet P, Renard E. et al . Dupuytren’s disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus.  J Hand Surg. 1995;  20 109-114
• 30 Gamstedt A, Holm-Glad J, Ohlson C G. et al . Hand abnormalities are strongly associated with the duration of diabetes mellitus.  J Intern Med. 1993;  234 189-193
• 31 Baumgarten K M, Gerlach D, Boyer M I. Corticosteroid injection in diabetic patients with trigger finger. A prospective, randomized, controlled double-blinded study.  J Bone Joint Surg Am. 2007;  89 2604-2611
• 32 Kameyama M, Funae O, Meguro S. et al . HbA1c values determine the outcome of intrasheath injection of triamcinolone for diabetic flexor tenosynovitis.  Diabetes care. 2006;  29 2512-2514
• 33 Arkkila P E, Kantola I M, Viikari J S. Dupuytren’s disease: association with chronic diabetic complications.  J Rheumatol. 1997;  24 153-159
• 34 Pal B, Anderson J, Dick W C. et al . Limitation of joint mobility and shoulder capsulitis in insulin- and non-insulin-dependent diabetes mellitus.  Br J Rheumatol. 1986;  25 147-151
• 35 Cagliero E, Maiello M, Boeri D. et al . Increased expression of basement membrane components in human endothelial cells cultured in high glucose.  J Clin Invest. 1988;  82 735-738
• 36 Badalamente M A, Sampson S P, Hurst L C. et al . The role of transforming growth factor beta in Dupuytren’s disease.  J Hand Surg. 1996;  21 210-215
• 37 Norotte G, Apoil A, Travers V. A ten years follow-up of the results of surgery for Dupuytren’s disease. A study of fifty-eight cases.  Ann Chir Main. 1988;  7 277-281
• 38 Geoghegan J M, Clark D I, Bainbridge L C. et al . Risk factors in carpal tunnel syndrome.  J Hand Surg. 2004;  29 315-320
• 39 Becker J, Nora D B, Gomes I. et al . An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome.  Clin Neurophysiol. 2002;  113 1429-1434
• 40 Rempel D, Evanoff B, Amadio P C. et al . Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies.  Am J Public Health. 1998;  88 1447-1451
• 41 O’Connor D, Marshall S, Massy-Westropp N. Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome.  Cochrane Database Syst Rev. 2003;  CD003219
• 42 Aszmann O C, Kress K M, Dellon A L. Results of decompression of peripheral nerves in diabetics: a prospective, blinded study.  Plast Reconstr Surg. 2000;  106 816-822
• 43 Scholten R J, Gerritsen A A, Uitdehaag B M. et al . Surgical treatment options for carpal tunnel syndrome.  Cochrane Database Syst Rev. 2004;  CD003905
• 44 Pinzur M S. Benchmark analysis of diabetic patients with neuropathic (Charcot) foot deformity.  Foot Ankle Int. 1999;  20 564-567
• 45 Hartemann-Heurtier A, Van G H, Grimaldi A. The Charcot foot.  Lancet. 2002;  360 1776-1779
• 46 Jeffcoate W J, Game F, Cavanagh P R. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes.  Lancet. 2005;  366 2058-2061
• 47 Fabrin J, Larsen K, Holstein P E. Long-term follow-up in diabetic Charcot feet with spontaneous onset.  Diabetes care. 2000;  23 796-800
• 48 Petrova N L, Foster A V, Edmonds M E. Difference in presentation of charcot osteoarthropathy in type 1 compared with type 2 diabetes.  Diabetes care. 2004;  27 1235-1236
• 49 Sella E J, Grosser D M. Imaging modalities of the diabetic foot.  Clin Podiatr Med Surg. 2003;  20 729-740
• 50 Sander L J. Charcot Neuroarthropathy of the Foot: Evaluation: Techniques and Nonsurgical Management. O`Neal’s La The Diabetic Foot Mosby sixth edition
• 51 Pinzur M S, Sage R, Stuck R. et al . A treatment algorithm for neuropathic (Charcot) midfoot deformity.  Foot Ankle. 1993;  14 189-197
• 52 Jude E B, Selby P L, Burgess J. et al . Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.  Diabetologia. 2001;  44 2032-2037
• 53 Forestier J, Rotes-Querol J. Senile ankylosing hyperostosis of the spine.  Ann Rheum Dis. 1950;  9 321-330
• 54 Resnick D, Shapiro R F, Wiesner K B. et al . Diffuse idiopathic skeletal hyperostosis (DISH) (ankylosing hyperostosis of Forestier and Rotes-Querol).  Semin Arthritis Rheum. 1978;  7 153-187
• 55 Ehara S, Shimamura T, Nakamura R. et al . Paravertebral ligamentous ossification: DISH, OPLL and OLF.  Eur J Radiol. 1998;  27 196-205
• 56 Benjamin M, Kumai T, Milz S. et al . The skeletal attachment of tendons – tendon “entheses”.  Comp Biochem Physiol A Mol Integr Physiol. 2002;  133 931-945
• 57 Weinfeld R M, Olson P N, Maki D D. et al . The prevalence of diffuse idiopathic skeletal hyperostosis (DISH) in two large American Midwest metropolitan hospital populations.  Skeletal Radiol. 1997;  26 222-225
• 58 Kiss C, Szilágyi M, Paksy A. et al . Risk factors for diffuse idiopathic skeletal hyperostosis: a case-control study.  Rheumatology. 2002;  41 27-30
• 59 Sencan D, Elden H, Nacitarhan V. et al . The prevalence of diffuse idiopathic skeletal hyperostosis in patients with diabetes mellitus.  Rheumatol Int. 2005;  25 518-521
• 60 el Miedany Y M, Wassif G, el B addini M. Diffuse idiopathic skeletal hyperostosis (DISH): is it of vascular aetiology?.  Clin Exp Rheumatol. 2000;  18 193-200
• 61 Denko C W, Boja B, Moskowitz R W. Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis – insulin, insulin-like growth factor-I, growth hormone.  J Rheumatol. 1994;  21 1725-1730
• 62 Sarzi-Puttini P, Atzeni F. New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis).  Curr Opin Rheumatol. 2004;  16 287-292
• 63 Cagliero E. Rheumatic manifestations of diabetes mellitus.  Curr Rheumatol Rep. 2003;  5 189-194